The present invention discloses an engineered bacteriophage comprising a polynucleotide encoding a heterologous protein under the control of a repressible promoter. Also disclosed are processes for producing the engineered bacteriophage, pharmaceutical compositions comprising the engineered bacteriophage and methods of treatment using the engineered bacteriophage.
Patent
2025-03-20T00:00:00+00:00